Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;14(2):149-608.
doi: 10.1002/alr.23262. Epub 2024 Jan 2.

International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

Edward C Kuan  1 Eric W Wang  2 Nithin D Adappa  3 Daniel M Beswick  4 Nyall R London Jr  5   6 Shirley Y Su  7 Marilene B Wang  4 Waleed M Abuzeid  8 Borislav Alexiev  9 Jeremiah A Alt  10 Paolo Antognoni  11 Michelle Alonso-Basanta  12 Pete S Batra  13 Mihir Bhayani  13 Diana Bell  14 Manuel Bernal-Sprekelsen  15 Christian S Betz  16 Jean-Yves Blay  17 Benjamin S Bleier  18 Juliana Bonilla-Velez  8 Claudio Callejas  19   20 Ricardo L Carrau  20 Roy R Casiano  21 Paolo Castelnuovo  22 Rakesh K Chandra  23 Vasileios Chatzinakis  24 Simon B Chen  25 Alexander G Chiu  26 Garret Choby  27 Naweed I Chowdhury  23 Martin J Citardi  28 Marc A Cohen  29 Roi Dagan  30 Gianluca Dalfino  22 Iacopo Dallan  31 Camila Soares Dassi  32 John de Almeida  33 Angelo P Dei Tos  34 John M DelGaudio  35 Charles S Ebert  36 Ivan H El-Sayed  37 Jean Anderson Eloy  38 James J Evans  39 Christina H Fang  40 Nyssa F Farrell  41 Marco Ferrari  42 Nancy Fischbein  43 Adam Folbe  44 Wytske J Fokkens  45 Meha G Fox  46 Valerie J Lund  47 Gary L Gallia  48 Paul A Gardner  49 Mathew Geltzeiler  50 Christos Georgalas  51 Anne E Getz  52 Satish Govindaraj  53 Stacey T Gray  54 Jessica W Grayson  55 Bradley A Gross  49 Jordon G Grube  56 Ruifeng Guo  57 Patrick K Ha  37 Ashleigh A Halderman  58 Ehab Y Hanna  7 Richard J Harvey  59 Stephen C Hernandez  60 Adam L Holtzman  61 Claire Hopkins  62 Zhigang Huang  63 Zhenxiao Huang  63 Ian M Humphreys  8 Peter H Hwang  64 Alfred M Iloreta  53 Masaru Ishii  5 Michael E Ivan  65 Aria Jafari  8 David W Kennedy  3 Mohemmed Khan  53 Adam J Kimple  36 Todd T Kingdom  52 Anna Knisely  66 Ying-Ju Kuo  67 Devyani Lal  27 Eric D Lamarre  68 Ming-Ying Lan  69 Hien Le  70 Matt Lechner  71 Nancy Y Lee  72 Jivianne K Lee  73 Victor H Lee  74 Corinna G Levine  21 Jin-Ching Lin  75 Derrick T Lin  54 Brian C Lobo  76 Tran Locke  46 Amber U Luong  28 Kelly R Magliocca  77 Svetomir N Markovic  78 Gesa Matnjani  79 Erin L McKean  80 Cem Meço  81   82 William M Mendenhall  30 Loren Michel  83 Shorook Na'ara  37 Piero Nicolai  42 Daniel W Nuss  60 Gurston G Nyquist  84 Gretchen M Oakley  10 Kazuhiro Omura  85 Richard R Orlandi  10 Nobuyoshi Otori  85 Peter Papagiannopoulos  13 Zara M Patel  64 David G Pfister  83 Jack Phan  86 Alkis J Psaltis  87 Mindy R Rabinowitz  84 Murugappan Ramanathan Jr  5 Ryan Rimmer  88 Marc R Rosen  84 Olabisi Sanusi  89 Zoukaa B Sargi  21 Philippe Schafhausen  90 Rodney J Schlosser  91 Ahmad R Sedaghat  92 Brent A Senior  36 Raj Shrivastava  93 Raj Sindwani  68 Timothy L Smith  50 Kristine A Smith  94 Carl H Snyderman  1 C Arturo Solares  35 Satyan B Sreenath  95 Aldo Stamm  32 Katharina Stölzel  16 Baran Sumer  58 Pavol Surda  62 Bobby A Tajudeen  13 Lester D R Thompson  96 Brian D Thorp  36 Charles C L Tong  3 Raymond K Tsang  97 Justin H Turner  23 Mario Turri-Zanoni  22 Aaron M Udager  98 Thibaut van Zele  99 Kyle VanKoevering  20 Kevin C Welch  100 Sarah K Wise  35 Ian J Witterick  101 Tae-Bin Won  102 Stephanie N Wong  103 Bradford A Woodworth  55 Peter-John Wormald  87 William C Yao  28 Chien-Fu Yeh  69 Bing Zhou  63 James N Palmer  3
Affiliations
Review

International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

Edward C Kuan et al. Int Forum Allergy Rhinol. 2024 Feb.

Abstract

Background: Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology-based topics spanning the field.

Methods: In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence-Based Review with Recommendations, Evidence-Based Review, and Literature Review based on the level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses format, and completed sections underwent a thorough and iterative consensus-building process. The final document underwent rigorous synthesis and review prior to publication.

Results: The ICSNT document consists of four major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology-based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention.

Conclusion: As an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.

Keywords: adenocarcinoma; adenoid cystic carcinoma; adjuvant therapy; angiofibroma; biopsy; chemotherapy; concurrent; endoscopic endonasal approach; esthesioneuroblastoma; evidence-based medicine; head and neck cancer; head and neck oncology; immunotherapy; induction chemotherapy; inverted papilloma; lymphoma; margins; metastases; mucosal melanoma; nasopharyngeal carcinoma; neoadjuvant therapy; neuroectodermal carcinoma; neuroendocrine carcinoma; olfactory neuroblastoma; open approach; orbit; papilloma; quality of life; radiation; resectability; rhabdomyosarcoma; risk factors; sarcoma; sinonasal cancer; sinonasal malignancy; sinonasal neoplasm; sinonasal oncology; sinonasal papilloma; sinonasal tumor; sinonasal undifferentiated carcinoma; skull base; squamous cell carcinoma; surgery; surveillance; survival; survivorship.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Orlandi RR, Kingdom TT, Hwang PH, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(Suppl. 1):S22-209. https://doi.org/10.1002/alr.21695
    1. Patel ZM, Holbrook EH, Turner JH, et al. International Consensus Statement on Allergy and Rhinology: Olfaction. Int Forum Allergy Rhinol. 2022;12(4):327-680. https://doi.org/10.1002/alr.22929
    1. Wise SK, Damask C, Roland LT, et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis - 2023. Int Forum Allergy Rhinol. 2023;13(4):293-859. https://doi.org/10.1002/alr.23090
    1. Wise SK, Lin SY, Toskala E, et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108-352. https://doi.org/10.1002/alr.22073
    1. Wang EW, Zanation AM, Gardner PA, et al. ICAR: endoscopic skull-base surgery. Int Forum Allergy Rhinol. 2019;9(S3):S145-S365. https://doi.org/10.1002/alr.22326